Dr Christy discusses the data on using Ivermectin to prevent Covid-19 infections.

REFERENCES:
Marik Protocol:
https://www.evms.edu/media/evms_public/departments/internal_medicine/EVMS_Critical_Care_COVID-19_Protocol.pdf

InVitro Ivermectin study:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129059/

Argentina Study:
https://media.marinomed.com/8b/7a/c7/nota-journal-of-biomedical-research-safety-adn-efficacy-iota-carrageenan-and-ivermectin.pdf

France Nursing Home Study:
https://translate.google.com/translate?hl=en&sl=fr&u=https://www.sciencedirect.com/science/article/pii/S015196382030627X&prev=search&pto=aue

Egypt study:
https://assets.researchsquare.com/files/rs-100956/v2/39b225ad-5df4-4da7-9cbd-233bf26a0eb4.pdf

Population study in Africa:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698683/#bib0019

Epidemiological Data from Peru and other countries:
https://covid19criticalcare.com/i-mask-prophylaxis-treatment-protocol/epidemiologic-analyses-on-covid19-and-ivermectin/

In this video, Dr Peter McCullough, from the Baylor University Medical Center in Texas, explains how important early outpatient treatment is and presents guidelines for such treatment.
Hydroxychloroquine (HCQ), Ivermectin (IVM), zink, Favipiravir

Läckt video från kontrollrummet på covid-högkvarteret

Vladimir Zelenko on HighWire July 2 2020 - hydroxychloroquine - covid19